| RS1131692212 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692213 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1131692214 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692215 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692216 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1131692217 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692219 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692220 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692221 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692222 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1131692223 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Hypercholesterolemia |
| RS1131692224 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692225 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692226 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS1131692227 |
KDM5C
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS1131692228 |
ACTL6B
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with severe speech and ambulation defects, Autism |
| RS1131692230 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS1131692231 |
CYFIP2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 65 |
| RS1131692232 |
PUF60
|
Health Risk |
Pathogenic/Likely pathogenic |
8q24.3 microdeletion syndrome, Inborn genetic diseases |
| RS1131692233 |
KIF5A
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 10, Hereditary spastic paraplegia 10 |
| RS1131692234 |
DNAH1
|
Health Risk |
Pathogenic |
Spermatogenic failure 18, Spermatogenic failure 18 |
| RS1131692235 |
SGPL1
|
Health Risk |
Pathogenic |
Nephrotic syndrome 14, Nephrotic syndrome 14 |
| RS1131692237 |
ERBB2
|
Health Risk |
Pathogenic |
Lung adenocarcinoma, Lung adenocarcinoma |
| RS1131692238 |
CDK12
|
Health Risk |
Likely pathogenic |
Lung adenocarcinoma, Lung adenocarcinoma |
| RS1131692243 |
PIK3R1
|
Health Risk |
Pathogenic |
Vascular Malformations and Overgrowth, Vascular Malformations and Overgrowth |
| RS1131692245 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1131692246 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1131692247 |
MYMK
|
Health Risk |
Pathogenic |
Congenital nonprogressive myopathy with Moebius and Robin sequences, Congenital nonprogressive myopathy with Moebius and Robin sequences |
| RS1131692248 |
MYMK
|
Health Risk |
Pathogenic |
Congenital nonprogressive myopathy with Moebius and Robin sequences, Congenital nonprogressive myopathy with Moebius and Robin sequences |
| RS1131692249 |
MYMK
|
Health Risk |
Pathogenic |
Congenital nonprogressive myopathy with Moebius and Robin sequences, Congenital nonprogressive myopathy with Moebius and Robin sequences |
| RS1131692250 |
DNAH1
|
Health Risk |
Pathogenic |
Spermatogenic failure 18, Spermatogenic failure 18 |
| RS1131692251 |
DNAH1
|
Health Risk |
Pathogenic |
Spermatogenic failure 18, Spermatogenic failure 18 |
| RS1131692252 |
SGPL1
|
Health Risk |
Pathogenic |
Nephrotic syndrome 14, Nephrotic syndrome 14 |
| RS1131692253 |
SGPL1
|
Health Risk |
Pathogenic |
Nephrotic syndrome 14, Nephrotic syndrome 14 |
| RS1131692254 |
SGPL1
|
Health Risk |
Pathogenic |
Nephrotic syndrome 14, Nephrotic syndrome 14 |
| RS1131692255 |
SGPL1
|
Health Risk |
Pathogenic |
Nephrotic syndrome 14, Nephrotic syndrome 14 |
| RS1131692256 |
SGPL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephrotic syndrome 14, Nephrotic syndrome |
| RS1131692258 |
EBF3
|
Health Risk |
Pathogenic |
Hypotonia, ataxia |
| RS1131692259 |
EBF3
|
Health Risk |
Pathogenic |
— |
| RS1131692260 |
EBF3
|
Health Risk |
Likely pathogenic |
— |
| RS1131692261 |
EBF3
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Hypotonia |
| RS1131692262 |
EBF3
|
Health Risk |
Likely pathogenic |
— |
| RS1131692263 |
ARID1B
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS1131692266 |
CFAP43
|
Health Risk |
Pathogenic |
Spermatogenic failure 19, Spermatogenic failure 19 |
| RS1131692268 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1131692269 |
WDFY3
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS1131692270 |
POGZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1131692272 |
AFF3
|
Health Risk |
Pathogenic |
KINSSHIP syndrome, Inborn genetic diseases |
| RS1131692274 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1131692279 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS1131692280 |
PKD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant polycystic kidney disease, Inborn genetic diseases |
| RS1131692282 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1131692284 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1131692285 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692286 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1131692287 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692289 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692290 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692291 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692292 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1131692293 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1131692294 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692295 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692296 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692297 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1131692298 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692299 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692300 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692301 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692302 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692303 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692304 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1131692305 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692306 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692307 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692308 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1131692309 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1131692310 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692312 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692313 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692314 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1131692315 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692316 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692317 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692318 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692319 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1131692320 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type III, Osteogenesis imperfecta type III |
| RS1131692325 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1131692326 |
COL1A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type I, COL1A1-related disorder |
| RS1131692327 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome 2, Long QT syndrome 2 |
| RS1131692328 |
NSD1
|
Health Risk |
Pathogenic |
Sotos syndrome, Sotos syndrome |
| RS1131692330 |
TRIP13
|
Health Risk |
Pathogenic |
Mosaic variegated aneuploidy syndrome 3, Mosaic variegated aneuploidy syndrome 3 |
| RS1131692331 |
SLC30A9
|
Health Risk |
Pathogenic |
Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome, Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome |
| RS1131692332 |
HPS6
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 6, Hermansky-Pudlak syndrome 6 |
| RS1131692333 |
HPS6
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 6, Hermansky-Pudlak syndrome 6 |
| RS1131695 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS113170280 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS113173389 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Fabry disease |
| RS113174390 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Nemaline myopathy 2 |
| RS113178142 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |